0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2007;297(11):1163. doi:10.1001/jama.297.11.1163.
Text Size: A A A
Published online

CV EVENT RATES IN OUTPATIENTS AT RISK

In an analysis of data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry, an international prospective cohort of patients with established atherosclerotic arterial disease or at least 3 risk factors for atherothrombosis, Steg and REACH Registry coinvestigatorsArticle assessed 1-year rates of cardiovascular (CV) death, myocardial infarction, and stroke in outpatients. The investigators found high 1-year rates of CV events. Event rates were 2 to 3 times higher among patients with established disease vs those with risk factors only, and these rates were increased among patients with symptomatic disease in multiple locations. In an editorial, McDermottArticle discusses the increasing burden of chronic cardiovascular disease.

SECONDARY NEOPLASMS AFTER CHILDHOOD ALL

Secondary neoplasms are a concern among long-term survivors of cancer therapy. Hijiya and colleagues investigated the incidence and characteristics of secondary neoplasms in a cohort of patients who were treated for childhood acute lymphoblastic leukemia (ALL) between 1962 and 1998 and had a median follow-up time of 18.7 years. The authors report that the cumulative incidence of secondary neoplasms was 4.17% (SE, 0.46%) at 15 years and increased to 10.85% (SE, 1.27%) at 30 years of follow-up, representing a significantly increased risk compared with that of the general population.

PAYMENTS TO PHYSICIANS BY PHARMACEUTICAL COMPANIES

Five states and the District of Columbia have mandated disclosure of pharmaceutical company payments to physicians. Ross and colleaguesArticle investigated the accessibility and quality of these data and the prevalence and magnitude of the payments from 2 states, Minnesota and Vermont. The authors report multiple challenges to data accessibility, including company designation of the data as “trade secrets” and missing data. Payments to physicians often exceeded the $100 maximum recommended by professional organizations. In an editorial, Brennan and MelloArticle discuss how the study findings may further undermine public trust in the pharmaceutical industry and regulatory efforts.

TRENDS IN BLACK-WHITE LIFE EXPECTANCY GAP IN THE US

Life expectancy at birth is lower for blacks than whites and in the past several decades, this black-white “gap” increased and then declined for reasons not yet explained. Harper and colleagues analyzed national vital statistics data from 1983 to 2003 to examine the contribution of specific age groups and causes of death to changes in the black-white life expectancy gap. Among the authors' findings were that increased mortality among blacks from human immunodeficiency virus (HIV) and heart disease widened the gap between 1983 and 1993, and declines since 1993 can be attributed to mortality improvements in homicide, HIV, unintentional injuries, and, among women, heart disease.

ELIGIBILITY CRITERIA OF RANDOMIZED CONTROLLED TRIALS

Selective eligibility criteria are central to the feasibility and internal validity of randomized controlled trials (RCTs) but may compromise the generalizability of the trial results. Van Spall and colleagues conducted a systematic review of RCTs published between 1994 and 2006 and found that common medical conditions, age, concomitant medications, and female sex were frequent exclusion criteria. Exclusions were particularly common in drug intervention trials and often were not justified in the context of the trial.

A PIECE OF MY MIND

“Maybe we should talk about putting methods in place to attract those students who enter medicine because they care, not because they can.” From “Endangered Species.”

MEDICAL NEWS & PERSPECTIVES

Spurred by concerns about a potential pandemic arising from H5N1 avian influenza, experts are working to establish effective pandemic preparedness strategies at the national, state, and local levels.

CLINICIAN'S CORNER

In a systematic review and meta-analysis of clinical trials, Hutton and HassanArticle found that in full-term infants, a 2-minute delay in umbilical cord clamping is associated with improved hematologic status. In an editorial, OhArticle discusses implications of this finding for clinical practice.

AUDIO COMMENTARY

Dr DeAngelis summarizes and comments on this week's issue. Go to http://jama.ama-assn.org/misc/audiocommentary.dtl.

JAMA PATIENT PAGE

For your patients: Information about acute lymphoblastic leukemia.

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

830 Views
0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

×